Please assess the completion status of the following clinical trial:

Trial Title: Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* The patient must have a diagnosis of pharyngitis with objective findings of tonsillo-pharyngitis.~* The patient is willing to take nothing by mouth including inhaled treatments except trial medication during the two hours while at the site and following trial drug administration (e.g. not smoking, food, drink, candy, lozenges, chewing gum). The patient will be allowed food and drink between hours 2 and 24, but no other oral or inhaled treatments such as smoking, lozenges, chewing gum. After the two hour assessment, the patients will be allowed food and drink within one half-hour following any hourly evaluations sore throat.~Exclusion Criteria:~* The patient has used any analgesic/antipyretic within 1 dosing interval preceding administration of the first dose of trial medication.~* The patient anticipates using any inhaled therapy including beta-agonists (e.g., ventolin) during the 24 hour trial period and, if used, has only used inhaled therapy on an intermittent basis in the week prior to the screening visit.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- celecoxib 50 mg/50 mg (Type: EXPERIMENTAL): None
- celecoxib 100 mg/placebo (Type: EXPERIMENTAL): None
- celecoxib 100 mg/50 mg (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).